brimonidine 0.2%/timolol 0.5% fixed combination ophthalmic solution

DRUG2 trials

Sponsors

Allergan

Conditions

GlaucomaGlaucoma, Angle-ClosureOcular Hypertension

Phase 3

Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients

CompletedNCT00651612

AllerganGlaucoma, Ocular Hypertension

Start: 2005-11-30End: 2007-01-31Updated: 2008-04-03

Phase 4

Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients

TerminatedNCT01151904

AllerganGlaucoma, Angle-Closure

Start: 2009-11-30End: 2012-02-29Updated: 2013-02-06